Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Aldeyra Therapeutics Initiates Phase 2 Clinical Trial of ADX-2191 for the Treatment of Retinitis Pigmentosa
Wednesday, March 09, 2022Aldeyra Therapeutics Inc a biotechnology company discovering and developing innovative therapies for the treatment of immunemediated diseases today announced that it has initiated a Phase clinical trial of ADX intravitreal methotrexate an investiga...
EKF Life Sciences and ABEC Partner for US Biomanufacturing Expansion
Wednesday, March 09, 2022ABEC a leading global provider of engineered solutions and services for biotech manufacturing today announced it will provide customized largescale bioprocess equipment including a liter total volume stainless steel fermenter and an liter media pre...
UCB Completes Acquisition of Zogenix, Inc.
Tuesday, March 08, 2022UCB today announced the successful completion of the previously announced transaction to acquire Zogenix NASDAQ ZGNX for US per share plus a milestonebased contingent value right for a potential cash payment of US per share The total transaction is...
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
Tuesday, March 08, 2022Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd announced today the launch of a first generic version of Revlimid lenalidomide capsules in mg mg mg and mg strengths in the United States
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Friday, March 04, 2022Inhibrx Inc a biotechnology company with four clinical programs in development and a strong emerging pipeline today announced that the US Food and Drug Administration or FDA has granted orphandrug designation for INBRX for the treatment of alpha anti...
BeiGene Announces Health Canada Approval for BRUKINSA® (zanubrutinib) in Relapsed or Refractory Marginal Zone Lymphoma
Friday, March 04, 2022BeiGene a global sciencedriven biotechnology company focused on developing innovative and affordable medicines today announced that BRUKINSA zanubrutinib has been approved by Health Canada for the treatment of adult patients with marginal zone lympho...
Newomics and Bruker Announce Collaborations on High-throughput Bioanalysis
Thursday, March 03, 2022Newomics Inc a biotechnology company commercializing mass spectrometry solutions for molecular detection and Bruker Corporation with differentiated highvalue life science research and diagnostics solutions today announced collaborations on a novel LC...
GC Labs and Two Clinical Diagnostic Companies Enter the Collaboration for the New Lab Testing Service
Thursday, March 03, 2022GC Labs CEO Dr Eunhee Lee the leading clinical diagnostics company in Korea today announced the new lab testing service agreement with two partners Bio Lab in Bahrain and Biotrust in Cambodia Since the start of year GC Labs has actively established...
Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership
Wednesday, March 02, 2022Ray Therapeutics a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions and Forge Biologics a gene therapyfocused contract development and manufacturing organization announced a manufacturing p...
Amneal Enters U.S. Biosimilars Market With Approval of RELEUKOTM (filgrastim-ayow)
Wednesday, March 02, 2022Amneal Pharmaceuticals Inc announced the US Food and Drug Administration FDA approval of the Biologics License Application BLA for filgrastimayow a biosimilar referencing Neupogen The product will be marketed under the proprietary name RELEUKOTM RELE...
